Publication | Closed Access

Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma

Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderHematologyImmunologyPathologyAggressive LymphomaImmunotherapyOncologyAdult T-cell Leukemia-lymphomaSequential Therapy